{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:14Z","timestamp":1786981514844,"version":"build-2736575974"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09952-1","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T03:03:04Z","timestamp":1727060584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Potential of Edaravone Dexborneol in the treatment of cerebral ischemia: focus on cell death-related signaling pathways"],"prefix":"10.1007","volume":"51","author":[{"given":"Fatemeh","family":"Rahmati-Dehkordi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Khanifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Zare-Hoseinabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Dadgostar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Jafarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid Reza","family":"Tamtaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"issue":"8","key":"9952_CR1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.116.025250","volume":"135","author":"W Wang","year":"2017","unstructured":"Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L et al (2017) Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation 135(8):759\u2013771","journal-title":"Circulation"},{"issue":"10159","key":"9952_CR2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"Z Darzynkiewicz","year":"2018","unstructured":"Darzynkiewicz Z, Zhao H, Zhang S, Marietta YL, Ernest YL, Zhang Z (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (Lond Engl). 392(10159):1789\u20131858","journal-title":"Lancet (Lond Engl)."},{"issue":"10244","key":"9952_CR3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(20)31179-X","volume":"396","author":"BCV Campbell","year":"2020","unstructured":"Campbell BCV, Stroke KP (2020) Stroke mimics: incidence, aetiology, clinical features and treatment. Lancet (Lond Engl) 396(10244):129\u2013142","journal-title":"Lancet (Lond Engl)"},{"issue":"1","key":"9952_CR4","first-page":"8405370","volume":"2020","author":"CD S\u00e1nchez-Hern\u00e1ndez","year":"2020","unstructured":"S\u00e1nchez-Hern\u00e1ndez CD, Torres-Alarc\u00f3n LA, Gonz\u00e1lez-Cort\u00e9s A, Pe\u00f3n AN (2020) Ischemia\/reperfusion injury: pathophysiology, current clinical management, and potential preventive approaches. Mediators Inflamm 2020(1):8405370","journal-title":"Mediators Inflamm"},{"issue":"1","key":"9952_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/med.21817","volume":"42","author":"QZ Tuo","year":"2022","unstructured":"Tuo QZ, Zhang ST, Lei P (2022) Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev 42(1):259\u2013305","journal-title":"Med Res Rev"},{"issue":"4","key":"9952_CR6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","volume":"13","author":"J Anrather","year":"2016","unstructured":"Anrather J, Iadecola C (2016) Inflammation and stroke: an overview. Neurotherapeutics 13(4):661\u2013670","journal-title":"Neurotherapeutics"},{"issue":"6","key":"9952_CR7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s12975-020-00806-z","volume":"11","author":"A Datta","year":"2020","unstructured":"Datta A, Sarmah D, Mounica L, Kaur H, Kesharwani R, Verma G et al (2020) Cell death pathways in ischemic stroke and targeted pharmacotherapy. Transl Stroke Res 11(6):1185\u20131202","journal-title":"Transl Stroke Res"},{"issue":"14","key":"9952_CR8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2015.3058","volume":"313","author":"S Prabhakaran","year":"2015","unstructured":"Prabhakaran S, Ruff I, Bernstein RA (2015) Acute stroke intervention: a systematic review. JAMA 313(14):1451\u20131462","journal-title":"JAMA"},{"key":"9952_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.wneu.2017.11.076","volume":"110","author":"CJ Griessenauer","year":"2018","unstructured":"Griessenauer CJ, Medin C, Maingard J, Chandra RV, Ng W, Brooks DM et al (2018) Endovascular mechanical thrombectomy in large-vessel occlusion ischemic stroke presenting with low national institutes of health stroke scale: systematic review and meta-analysis. World Neurosurg 110:263\u2013269","journal-title":"World Neurosurg"},{"issue":"3","key":"9952_CR10","first-page":"8","volume":"4","author":"J Xu","year":"2019","unstructured":"Xu J, Wang Y, Wang A, Gao Z, Gao X, Chen H et al (2019) Safety and efficacy of Edaravone Dexborneol versus Edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial. Stroke Vasc Neurol 4(3):8","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"9952_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13578-024-01230-8","volume":"14","author":"C Xu","year":"2024","unstructured":"Xu C, Mei Y, Yang R, Luo Q, Zhang J, Kou X et al (2024) Edaravone Dexborneol mitigates pathology in animal and cell culture models of Alzheimer\u2019s disease by inhibiting neuroinflammation and neuronal necroptosis. Cell Biosci 14(1):55","journal-title":"Cell Biosci"},{"key":"9952_CR12","volume":"13","author":"Q Chen","year":"2022","unstructured":"Chen Q, Cai Y, Zhu X, Wang J, Gao F, Yang M et al (2022) Edaravone Dexborneol treatment attenuates neuronal apoptosis and improves neurological function by suppressing 4-HNE-associated oxidative stress after subarachnoid hemorrhage. Front Pharmacol 13:848529","journal-title":"Front Pharmacol"},{"key":"9952_CR13","doi-asserted-by":"crossref","unstructured":"Wang C, Gu HQ, Dong Q, Xu A, Wang N, Yang Y et al. (2024) Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial. Stroke Vasc Neurol.","DOI":"10.1136\/svn-2023-002938"},{"issue":"5","key":"9952_CR14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/fcp.12782","volume":"36","author":"L Xu","year":"2022","unstructured":"Xu L, Gao Y, Hu M, Dong Y, Xu J, Zhang J et al (2022) Edaravone Dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2\/HO-1 signaling pathway in mice. Fundam Clin Pharmacol 36(5):790\u2013800","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"9952_CR15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ar.25296","volume":"307","author":"G Shen","year":"2024","unstructured":"Shen G, Lou C, Li Q, Zhao B, Luo Y, Wu F et al (2024) Edaravone Dexborneol alleviates cerebral ischemia-reperfusion injury through NF-\u03baB\/NLRP3 signal pathway. Anatom Record (Hoboken, NJ\u202f: 2007) 307(2):372\u2013384","journal-title":"Anatom Record (Hoboken, NJ : 2007)"},{"key":"9952_CR16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2024.03.019","volume":"217","author":"P Xiao","year":"2024","unstructured":"Xiao P, Huang H, Zhao H, Liu R, Sun Z, Liu Y et al (2024) Edaravone Dexborneol protects against cerebral ischemia\/reperfusion-induced blood-brain barrier damage by inhibiting ferroptosis via activation of nrf-2\/HO-1\/GPX4 signaling. Free Radical Biol Med 217:116\u2013125","journal-title":"Free Radical Biol Med"},{"issue":"3","key":"9952_CR17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000069318","volume":"15","author":"K Mori","year":"2003","unstructured":"Mori K, Beppu T, Fujisawa Y, Onodera M, Ogasawara K, Sasaki M, Ehara S, Sakai A, Endo S, Group EAIS (2003) : Effect of a novel free radical scavenger, Edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 15(3):222\u2013229","journal-title":"Cerebrovasc Dis"},{"key":"9952_CR18","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s10072-015-2314-y","volume":"36","author":"R Yang","year":"2015","unstructured":"Yang R, Wang Q, Li F, Li J, Liu X (2015) Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer\u2019s disease. Neurol Sci 36:2067\u20132072","journal-title":"Neurol Sci"},{"key":"9952_CR19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s12031-013-9973-z","volume":"50","author":"G-l Zhang","year":"2013","unstructured":"Zhang G-l, Zhang W-g, Du Y, Yao L, Sun H, Zhang R et al (2013) Edaravone ameliorates oxidative damage associated with A\u03b225\u201335 treatment in PC12 cells. J Mol Neurosci 50:494\u2013503","journal-title":"J Mol Neurosci"},{"key":"9952_CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lfs.2019.02.025","volume":"221","author":"L Zhang","year":"2019","unstructured":"Zhang L, Guo Y, Wang H, Zhao L, Ma Z, Li T et al (2019) Edaravone reduces A\u03b2-induced oxidative damage in SH-SY5Y cells by activating the Nrf2\/ARE signaling pathway. Life Sci 221:259\u2013266","journal-title":"Life Sci"},{"issue":"2","key":"9952_CR21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s11064-022-03782-y","volume":"48","author":"S Guo","year":"2023","unstructured":"Guo S, Lei Q, Guo H, Yang Q, Xue Y, Chen R (2023) Edaravone attenuates A\u03b2 1\u201342-induced inflammatory damage and ferroptosis in HT22 cells. Neurochem Res 48(2):570\u2013578","journal-title":"Neurochem Res"},{"key":"9952_CR22","first-page":"1","volume":"5","author":"H Shi","year":"2024","unstructured":"Shi H, Song L, Wu Y, Shen R, Zhang C, Liao X et al (2024) Edaravone alleviates traumatic brain injury by inhibition of ferroptosis via FSP1 pathway. Mol Neurobiol 5:1\u201314","journal-title":"Mol Neurobiol"},{"key":"9952_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuro.2013.07.007","volume":"38","author":"S Zhou","year":"2013","unstructured":"Zhou S, Yu G, Chi L, Zhu J, Zhang W, Zhang Y et al (2013) Neuroprotective effects of Edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats. Neurotoxicology 38:136\u2013145","journal-title":"Neurotoxicology"},{"issue":"7","key":"9952_CR24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/ejn.13543","volume":"45","author":"K Reeta","year":"2017","unstructured":"Reeta K, Singh D, Gupta YK (2017) Edaravone attenuates intracerebroventricular streptozotocin-induced cognitive impairment in rats. Eur J Neurosci 45(7):987\u2013997","journal-title":"Eur J Neurosci"},{"key":"9952_CR25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s12013-014-0048-8","volume":"70","author":"X Liu","year":"2014","unstructured":"Liu X, Shao R, Li M, Yang G (2014) Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage. Cell Biochem Biophys 70:1247\u20131254","journal-title":"Cell Biochem Biophys"},{"key":"9952_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-9-75","volume":"9","author":"W Ji Yuan","year":"2008","unstructured":"Ji Yuan W, Yasuhara T, Shingo T, Muraoka K, Agari T, Kameda M et al (2008) Neuroprotective effects of Edaravone-administration on 6-OHDA-treated dopaminergic neurons. BMC Neurosci 9:1\u201311","journal-title":"BMC Neurosci"},{"key":"9952_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuint.2017.07.001","volume":"112","author":"Z Liu","year":"2018","unstructured":"Liu Z, Yang C, Meng X, Li Z, Lv C, Cao P (2018) Neuroprotection of Edaravone on the hippocampus of kainate-induced epilepsy rats through Nrf2\/HO-1 pathway. Neurochem Int 112:159\u2013165","journal-title":"Neurochem Int"},{"key":"9952_CR28","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Dai X, Zhou L, Li X, Pan D (2021) Edaravone plays protective effects on LPS-induced microglia by switching M1\/M2 phenotypes and regulating NLRP3 inflammasome activation. Front Pharmacol 12:691773","journal-title":"Front Pharmacol"},{"issue":"1","key":"9952_CR29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12974-022-02400-6","volume":"19","author":"R Dang","year":"2022","unstructured":"Dang R, Wang M, Li X, Wang H, Liu L, Wu Q et al (2022) Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway. J Neuroinflammation 19(1):41","journal-title":"J Neuroinflammation"},{"key":"9952_CR30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuroscience.2011.11.005","volume":"201","author":"P Zhang","year":"2012","unstructured":"Zhang P, Li W, Li L, Wang N, Li X, Gao M et al (2012) Treatment with Edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury. Neuroscience 201:297\u2013306","journal-title":"Neuroscience"},{"issue":"2","key":"9952_CR31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2005.04.036","volume":"516","author":"S Amemiya","year":"2005","unstructured":"Amemiya S, Kamiya T, Nito C, Inaba T, Kato K, Ueda M et al (2005) Anti-apoptotic and neuroprotective effects of Edaravone following transient focal ischemia in rats. Eur J Pharmacol 516(2):125\u2013130","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"9952_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/ph8020176","volume":"8","author":"S Okuyama","year":"2015","unstructured":"Okuyama S, Morita M, Sawamoto A, Terugo T, Nakajima M, Furukawa Y (2015) Edaravone enhances brain-derived neurotrophic factor production in the ischemic mouse brain. Pharmaceuticals 8(2):176\u2013185","journal-title":"Pharmaceuticals"},{"issue":"2","key":"9952_CR33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3892\/ijo.2020.5077","volume":"57","author":"H Yu","year":"2020","unstructured":"Yu H, Wu Z, Wang X, Gao C, Liu R, Kang F et al (2020) Protective effects of combined treatment with mild hypothermia and Edaravone against cerebral ischemia\/reperfusion injury via oxidative stress and Nrf2 pathway regulation. Int J Oncol 57(2):500\u2013508","journal-title":"Int J Oncol"},{"issue":"10","key":"9952_CR34","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.STR.0000182241.07096.06","volume":"36","author":"N Zhang","year":"2005","unstructured":"Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T (2005) Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36(10):2220\u20132225","journal-title":"Stroke"},{"key":"9952_CR35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuroscience.2010.11.029","volume":"176","author":"R Liu","year":"2011","unstructured":"Liu R, Zhang L, Lan X, Li L, Zhang T-T, Sun J-H et al (2011) Protection by borneol on cortical neurons against oxygen-glucose deprivation\/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor \u03baappaB signaling pathway. Neuroscience 176:408\u2013419","journal-title":"Neuroscience"},{"issue":"1","key":"9952_CR36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/13880209.2012.700718","volume":"51","author":"J Hur","year":"2013","unstructured":"Hur J, Pak SC, Koo B-S, Jeon S (2013) Borneol alleviates oxidative stress via upregulation of Nrf2 and Bcl-2 in SH-SY5Y cells. Pharm Biol 51(1):30\u201335","journal-title":"Pharm Biol"},{"key":"9952_CR37","volume":"1810","author":"F Gao","year":"2023","unstructured":"Gao F, Chen R, Li S, Li A, Bai B, Mi R et al (2023) (+)-Borneol exerts neuroprotective effects via suppressing the NF-\u03baB pathway in the pilocarpine-induced epileptogenesis rat model. Brain Res 1810:148382","journal-title":"Brain Res"},{"issue":"7","key":"9952_CR38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/antiox13070803","volume":"13","author":"Z Shen","year":"2024","unstructured":"Shen Z, Guo Y-D, Tang M-Z, Zhou P, Su Y-X, Shen H-R et al (2024) Dexborneol amplifies Pregabalin\u2019s analgesic effect in mouse models of peripheral nerve injury and incisional pain. Antioxidants 13(7):803","journal-title":"Antioxidants"},{"key":"9952_CR39","doi-asserted-by":"crossref","unstructured":"Fu Y, Wang A, Tang R, Li S, Tian X, Xia X et al. (2024) Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke: The TASTE-SL Randomized Clinical Trial. JAMA Neurol","DOI":"10.2139\/ssrn.4543608"},{"issue":"3","key":"9952_CR40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/svn-2018-000221","volume":"4","author":"J Xu","year":"2019","unstructured":"Xu J, Wang Y, Wang A, Gao Z, Gao X, Chen H et al (2019) Safety and efficacy of Edaravone Dexborneol versus Edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial. Stroke Vasc Neurol 4(3):109\u2013114","journal-title":"Stroke Vasc Neurol"},{"key":"9952_CR41","volume":"13","author":"F Shi","year":"2022","unstructured":"Shi F, He Z, Wang L, Su H, Han S (2022) Cost-effectiveness of Edaravone Dexborneol versus Edaravone for the treatment of acute ischemic stroke in China: based on the TASTE study. Front Pharmacol 13:938239","journal-title":"Front Pharmacol"},{"key":"9952_CR42","first-page":"1","volume":"7","author":"X Zhu","year":"2024","unstructured":"Zhu X, Jin Q, Liu X (2024) Advantages of Edaravone Dextrosanol in elderly patients with acute cerebral infarction versus Edaravone\u202f: a preliminary study. Int J Neurosci 7:1\u201321","journal-title":"Int J Neurosci"},{"issue":"1","key":"9952_CR43","first-page":"147","volume":"78","author":"J Xu","year":"2021","unstructured":"Xu J, Wang YJH (2021) Abstract P148: safety and efficacy of Edaravone Dexborneol versus Edaravone alone for the treatment of acute ischemic stroke patients with hypertention: analysis from taste trial. Hypertension 78(1):147","journal-title":"Hypertension"},{"issue":"Pt 2","key":"9952_CR44","volume":"266","author":"D Su","year":"2024","unstructured":"Su D, Zhang R, Wang X, Ding Q, Che F, Zhang W et al (2024) A new multi-parameter imaging platform for in vivo drug efficacy evaluation of ischemic stroke. Talanta 266(Pt 2):125133","journal-title":"Talanta"},{"issue":"3","key":"9952_CR45","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/STROKEAHA.120.031197","volume":"52","author":"J Xu","year":"2021","unstructured":"Xu J, Wang A, Meng X, Yalkun G, Xu A, Gao Z et al (2021) Edaravone Dexborneol versus edaravone alone for the treatment of acute ischemic stroke: a phase III, randomized, double-blind, comparative trial. Stroke 52(3):772\u2013780","journal-title":"Stroke"},{"issue":"1","key":"9952_CR46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12889-024-17959-3","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Cao W, Zhao F, Jin P (2024) Cost-effectiveness of Edaravone Dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective. BMC Public Health 24(1):436","journal-title":"BMC Public Health"},{"issue":"1","key":"9952_CR47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13561-024-00479-6","volume":"14","author":"P Chen","year":"2024","unstructured":"Chen P, Luo M, Chen Y, Zhang Y, Wang C, Li H (2024) Cost-effectiveness of Edaravone Dexborneol versus human urinary kallidinogenase for acute ischemic stroke in China. Heal Econ Rev 14(1):7","journal-title":"Heal Econ Rev"},{"issue":"1","key":"9952_CR48","doi-asserted-by":"crossref","first-page":"20220312","DOI":"10.1515\/tnsci-2022-0312","volume":"14","author":"X Hu","year":"2023","unstructured":"Hu X, Qian Z, Chen J, Chen M, Zhong W, Shen C et al (2023) Effects of Edaravone Dexborneol on neurological function and serum inflammatory factor levels in patients with acute anterior circulation large vessel occlusion stroke. Transl Neurosci 14(1):20220312","journal-title":"Transl Neurosci"},{"key":"9952_CR49","volume":"910","author":"Y Hua","year":"2021","unstructured":"Hua Y, Zhou L, Yang W, An W, Kou X, Ren J et al (2021) Y-2 reduces oxidative stress and inflammation and improves neurological function of collagenase-induced intracerebral hemorrhage rats. Eur J Pharmacol 910:174507","journal-title":"Eur J Pharmacol"},{"key":"9952_CR50","first-page":"89","volume":"5","author":"J Huang","year":"2024","unstructured":"Huang J, Hu X, Li J, Gong D (2024) Edaravone Dexborneol promotes M2 microglia polarization against lipopolysaccharide-induced inflammation via suppressing TLR4\/MyD88\/NF-\u03baB pathway. Naunyn-Schmiedeberg\u2019s Archives Pharmacol 5:89","journal-title":"Naunyn-Schmiedeberg's Archives Pharmacol"},{"key":"9952_CR51","doi-asserted-by":"crossref","first-page":"1167425","DOI":"10.3389\/fnins.2023.1167425","volume":"17","author":"P Liu","year":"2023","unstructured":"Liu P, Liu H, Wei L, Shi X, Wang W, Yan S et al (2023) Docetaxel-induced cognitive impairment in rats can be ameliorated by Edaravone dexborneol: evidence from the indicators of biological behavior and anisotropic fraction. Front Neurosci 17:1167425","journal-title":"Front Neurosci"},{"issue":"3","key":"9952_CR52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/antiox3030472","volume":"3","author":"R Shirley","year":"2014","unstructured":"Shirley R, Ord EN, Work LM (2014) Oxidative stress and the use of antioxidants in stroke. Antioxidants 3(3):472\u2013501","journal-title":"Antioxidants"},{"key":"9952_CR53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnmol.2020.00028","volume":"13","author":"L Wu","year":"2020","unstructured":"Wu L, Xiong X, Wu X, Ye Y, Jian Z, Zhi Z et al (2020) Targeting oxidative stress and inflammation to prevent ischemia-reperfusion injury. Front Mol Neurosci 13:28","journal-title":"Front Mol Neurosci"},{"issue":"34","key":"9952_CR54","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.2174\/1381612826666200708133912","volume":"26","author":"S Orellana-Urz\u00faa","year":"2020","unstructured":"Orellana-Urz\u00faa S, Rojas I, L\u00edbano L, Rodrigo R (2020) Pathophysiology of ischemic stroke: role of oxidative stress. Curr Pharm Des 26(34):4246\u20134260","journal-title":"Curr Pharm Des"},{"issue":"3","key":"9952_CR55","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94(3):909\u2013950","journal-title":"Physiol Rev"},{"issue":"3","key":"9952_CR56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.WCB.0000110047.43905.01","volume":"24","author":"S Liu","year":"2004","unstructured":"Liu S, Shi H, Liu W, Furuichi T, Timmins GS, Liu KJ (2004) Interstitial pO2 in ischemic penumbra and core are differentially affected following transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 24(3):343\u2013349","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"9952_CR57","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1046\/j.1471-4159.1999.0731549.x","volume":"73","author":"W Ying","year":"1999","unstructured":"Ying W, Han SK, Miller JW, Swanson RA (1999) Acidosis potentiates oxidative neuronal death by multiple mechanisms. J Neurochem 73(4):1549\u20131556","journal-title":"J Neurochem"},{"issue":"6","key":"9952_CR58","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","volume":"43","author":"MS D'Arcy","year":"2019","unstructured":"D\u2019Arcy MS (2019) Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 43(6):582\u2013592","journal-title":"Cell Biol Int"},{"issue":"2","key":"9952_CR59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15171\/apb.2019.024","volume":"9","author":"R Jan","year":"2019","unstructured":"Jan R (2019) Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv Pharm Bull 9(2):205","journal-title":"Adv Pharm Bull"},{"issue":"51","key":"9952_CR60","doi-asserted-by":"crossref","first-page":"20327","DOI":"10.1073\/pnas.0808036105","volume":"105","author":"JE Chipuk","year":"2008","unstructured":"Chipuk JE, Fisher JC, Dillon CP, Kriwacki RW, Kuwana T, Green DR (2008) Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci 105(51):20327\u201320332","journal-title":"Proc Natl Acad Sci"},{"key":"9952_CR61","doi-asserted-by":"crossref","first-page":"4013707","DOI":"10.1155\/2022\/4013707","volume":"2022","author":"W Zhang","year":"2022","unstructured":"Zhang W, Yang H, Gao M, Zhang H, Shi L, Yu X et al (2022) Edaravone Dexborneol alleviates cerebral ischemic injury via MKP-1-mediated inhibition of MAPKs and activation of Nrf2. Biomed Res Int 2022:4013707","journal-title":"Biomed Res Int"},{"key":"9952_CR62","doi-asserted-by":"crossref","first-page":"148917","DOI":"10.1016\/j.brainres.2024.148917","volume":"15","author":"H Guo","year":"2024","unstructured":"Guo H, Li H, Jia Z, Ma S, Zhang J (2024) Edaravone Dexborneol attenuates cognitive impairment in a rat model of vascular dementia by inhibiting hippocampal oxidative stress and inflammatory responses and modulating the NMDA receptor signaling pathway. Brain Res 15:148917","journal-title":"Brain Res"},{"key":"9952_CR63","volume":"178","author":"T Zhu","year":"2024","unstructured":"Zhu T, Wu B-W (2024) Recognition of necroptosis: from molecular mechanisms to detection methods. Biomed Pharmacother 178:117196","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"9952_CR64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299577","volume":"19","author":"SM Choudhury","year":"2024","unstructured":"Choudhury SM, Sarkar R, Karki R, Kanneganti T-D (2024) A comparative study of apoptosis, pyroptosis, necroptosis, and PANoptosis components in mouse and human cells. PLoS ONE 19(2):e0299577","journal-title":"PLoS ONE"},{"issue":"12","key":"9952_CR65","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.3390\/ijms241210127","volume":"24","author":"L Tang","year":"2023","unstructured":"Tang L, Liu S, Li S, Chen Y, Xie B, Zhou J (2023) Induction mechanism of ferroptosis, necroptosis, and pyroptosis: a novel therapeutic target in nervous system diseases. Int J Mol Sci 24(12):10127","journal-title":"Int J Mol Sci"},{"issue":"7","key":"9952_CR66","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1007\/s12035-023-03728-7","volume":"61","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yang F, Duo K, Liu Y, Yu J, Wu Q et al (2024) The role of necroptosis in cerebral ischemic stroke. Mol Neurobiol 61(7):3882\u20133898","journal-title":"Mol Neurobiol"},{"key":"9952_CR67","volume":"165","author":"B Xu","year":"2023","unstructured":"Xu B, Fang J, Wang J, Jin X, Liu S, Song K et al (2023) Inhibition of autophagy and RIP1\/RIP3\/MLKL-mediated necroptosis by Edaravone attenuates blood spinal cord barrier disruption following spinal cord injury. Biomed Pharmacother 165:115165","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"9952_CR68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.14715\/cmb\/2022.68.7.16","volume":"68","author":"G Zhao","year":"2022","unstructured":"Zhao G, Zhao L, Li Y, Wang L, Hu Z (2022) Influences of Edaravone on necroptosis-related proteins and oxidative stress in rats with lower extremity ischemia\/reperfusion injury. Cell Mol Biol (Noisy-le-grand) 68(7):95\u2013100","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"8","key":"9952_CR69","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/nu16081201","volume":"16","author":"D Wendlocha","year":"2024","unstructured":"Wendlocha D, Kubina R, Krzykawski K, Mielczarek-Palacz A (2024) Selected flavonols targeting cell death pathways in cancer therapy: the latest achievements in research on apoptosis, autophagy, necroptosis, pyroptosis, ferroptosis, and cuproptosis. Nutrients 16(8):1201","journal-title":"Nutrients"},{"issue":"13","key":"9952_CR70","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.3390\/ijms25137130","volume":"25","author":"Q Fan","year":"2024","unstructured":"Fan Q, Li R, Wei H, Xue W, Li X, Xia Z et al (2024) Research progress of Pyroptosis in Diabetic Kidney disease. Int J Mol Sci 25(13):7130","journal-title":"Int J Mol Sci"},{"key":"9952_CR71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109595","volume":"121","author":"Y Fang","year":"2020","unstructured":"Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y et al (2020) Pyroptosis: a new frontier in cancer. Biomed Pharmacother 121:109595","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"9952_CR72","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X (2021) Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 6(1):128","journal-title":"Signal Transduct Target Ther"},{"key":"9952_CR73","doi-asserted-by":"crossref","first-page":"2183026","DOI":"10.1155\/2016\/2183026","volume":"1","author":"L Minutoli","year":"2016","unstructured":"Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V et al (2016) ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia\/reperfusion injury. Oxid Med Cell Longev 1:2183026","journal-title":"Oxid Med Cell Longev"},{"key":"9952_CR74","volume":"15","author":"L Wang","year":"2022","unstructured":"Wang L, Ren W, Wu Q, Liu T, Wei Y, Ding J et al (2022) NLRP3 inflammasome activation: a therapeutic target for cerebral ischemia\u2013reperfusion injury. Front Mol Neurosci 15:847440","journal-title":"Front Mol Neurosci"},{"issue":"15","key":"9952_CR75","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1523\/JNEUROSCI.21-15-05528.2001","volume":"21","author":"H Boutin","year":"2001","unstructured":"Boutin H, LeFeuvre R, Horai R, Asano M, Iwakura Y, Rothwell N (2001) Role of IL-1\u03b1 and IL-1\u03b2 in ischemic brain damage. J Neurosci 21(15):5528\u20135534","journal-title":"J Neurosci"},{"key":"9952_CR76","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuint.2017.06.008","volume":"112","author":"C Chen","year":"2018","unstructured":"Chen C, Chu S-F, Liu D-D, Zhang Z, Kong L-L, Zhou X et al (2018) Chemokines play complex roles in cerebral ischemia. Neurochem Int 112:146\u2013158","journal-title":"Neurochem Int"},{"key":"9952_CR77","volume":"13","author":"H Zhu","year":"2022","unstructured":"Zhu H, Hu S, Li Y, Sun Y, Xiong X, Hu X et al (2022) Interleukins and ischemic stroke. Front Immunol 13:828447","journal-title":"Front Immunol"},{"issue":"9","key":"9952_CR78","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G (2022) NF-\u03baB: blending metabolism, immunity, and inflammation. Trends Immunol 43(9):757\u2013775","journal-title":"Trends Immunol"},{"issue":"18","key":"9952_CR79","doi-asserted-by":"crossref","first-page":"10235","DOI":"10.3390\/ijms231810235","volume":"23","author":"R Versele","year":"2022","unstructured":"Versele R, Sevin E, Gosselet F, Fenart L, Candela P (2022) TNF-\u03b1 and IL-1\u03b2 modulate blood-brain barrier permeability and decrease amyloid-\u03b2 peptide efflux in a human blood-brain barrier model. Int J Mol Sci 23(18):10235","journal-title":"Int J Mol Sci"},{"key":"9952_CR80","volume":"190","author":"Y Ji","year":"2023","unstructured":"Ji Y, Gao Q, Ma Y, Wang F, Tan X, Song D et al (2023) An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and reduces stroke patient-derived MMP-9 activity. Pharmacol Res 190:106720","journal-title":"Pharmacol Res"},{"issue":"1","key":"9952_CR81","doi-asserted-by":"crossref","first-page":"11344","DOI":"10.1038\/s41598-018-29341-6","volume":"8","author":"AF Logsdon","year":"2018","unstructured":"Logsdon AF, Meabon JS, Cline MM, Bullock KM, Raskind MA, Peskind ER et al (2018) Blast exposure elicits blood-brain barrier disruption and repair mediated by tight junction integrity and nitric oxide dependent processes. Sci Rep 8(1):11344","journal-title":"Sci Rep"},{"issue":"1\u20133","key":"9952_CR82","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/ars.2021.0072","volume":"37","author":"S Chen","year":"2022","unstructured":"Chen S, Li L, Peng C, Bian C, Ocak PE, Zhang JH et al (2022) Targeting oxidative stress and inflammatory response for blood\u2013brain barrier protection in intracerebral hemorrhage. Antioxid Redox Signal 37(1\u20133):115\u2013134","journal-title":"Antioxid Redox Signal"},{"issue":"Pt A","key":"9952_CR83","volume":"113","author":"R Hu","year":"2022","unstructured":"Hu R, Liang J, Ding L, Zhang W, Liu X, Song B et al (2022) Edaravone Dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke. Int Immunopharmacol 113(Pt A):109315","journal-title":"Int Immunopharmacol"},{"key":"9952_CR84","first-page":"3855698","volume":"2022","author":"Y Huang","year":"2022","unstructured":"Huang Y, Zhang X, Zhang C, Xu W, Li W, Feng Z et al (2022) Edaravone Dexborneol Downregulates neutrophil extracellular trap expression and ameliorates blood-brain barrier permeability in acute ischemic stroke. Mediators Inflamm 2022:3855698","journal-title":"Mediators Inflamm"},{"key":"9952_CR85","volume":"130","author":"D Wang","year":"2024","unstructured":"Wang D, Wang Y, Shi J, Jiang W, Huang W, Chen K et al (2024) Edaravone Dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration. Int Immunopharmacol 130:111700","journal-title":"Int Immunopharmacol"},{"key":"9952_CR86","doi-asserted-by":"crossref","unstructured":"Wang D, Wang Y, Jiang W, Shi J, Huang W, Cao C, et al. (2023) EDB-mediated neuroprotection against acute ischemic brain injury is associated with reduced central and peripheral inflammation","DOI":"10.21203\/rs.3.rs-3242115\/v1"},{"issue":"11","key":"9952_CR87","volume":"32","author":"Y Xi","year":"2023","unstructured":"Xi Y, Ma J, Lu S (2023) Favorable neuroprotective effect of intra-arterial application of Edaravone Dexborneol in ischemic stroke rats. J Stroke Cerebrovasc Dis 32(11):107356","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9952_CR88","volume":"957","author":"L Li","year":"2023","unstructured":"Li L, He G, Shi M, Zhu J, Cheng Y, Chen Y et al (2023) Edaravone Dexborneol ameliorates cognitive impairment by regulating the NF-\u03baB pathway through AHR and promoting microglial polarization towards the M2 phenotype in mice with bilateral carotid artery stenosis (BCAS). Eur J Pharmacol 957:176036","journal-title":"Eur J Pharmacol"},{"key":"9952_CR89","first-page":"17","volume":"8","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang Y, Mu Y, Cao X, Ge K, Geng DJCJOBM et al (2022) Effect of Edaravone Dexborneol on anxious-and depressive-like behaviors and its mechanism in rats with cerebral ischemia-reperfusion. Chin J Behav Med Brain Sci 8:17\u201324","journal-title":"Chin J Behav Med Brain Sci"},{"key":"9952_CR90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123748","volume":"651","author":"C Teng","year":"2024","unstructured":"Teng C, Lv W, Chen Y, Liu L, Yin J, Li S et al (2024) Enhanced the treatment of ischemic stroke through intranasal temperature-sensitive hydrogels of Edaravone and borneol inclusion complex. Int J Pharm 651:123748","journal-title":"Int J Pharm"},{"key":"9952_CR91","volume":"951","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang L, Zhu B, Yang Y, Cai C, Wang X et al (2023) A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and Edaravone Dexborneol on cerebral ischemic stroke rats. Eur J Pharmacol 951:175801","journal-title":"Eur J Pharmacol"},{"issue":"5\u20136","key":"9952_CR92","first-page":"382","volume":"40","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Dixon SJ (2019) Ferroptosis and brain injury. Dev Neurosci 40(5\u20136):382\u2013395","journal-title":"Dev Neurosci"},{"issue":"3","key":"9952_CR93","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/biology10030184","volume":"10","author":"J-Y Lee","year":"2021","unstructured":"Lee J-Y, Kim WK, Bae K-H, Lee SC, Lee E-W (2021) Lipid metabolism and ferroptosis. Biology 10(3):184","journal-title":"Biology"},{"issue":"8","key":"9952_CR94","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s12276-023-01077-y","volume":"55","author":"JW Kim","year":"2023","unstructured":"Kim JW, Lee J-Y, Oh M, Lee E-W (2023) An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis. Exp Mol Med 55(8):1620\u20131631","journal-title":"Exp Mol Med"},{"key":"9952_CR95","doi-asserted-by":"crossref","unstructured":"Pope LE, Dixon SJ (2023) Regulation of ferroptosis by lipid metabolism. Trends Cell Biol","DOI":"10.1016\/j.tcb.2023.05.003"},{"issue":"4","key":"9952_CR96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"9952_CR97","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11033-022-08048-y","volume":"50","author":"Y Xu","year":"2023","unstructured":"Xu Y, Zhao J, Zhao Y, Zhou L, Qiao H, Xu Q et al (2023) The role of ferroptosis in neurodegenerative diseases. Mol Biol Rep 50(2):1655\u20131661","journal-title":"Mol Biol Rep"},{"issue":"1","key":"9952_CR98","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1038\/s41598-024-53836-0","volume":"14","author":"W Fan","year":"2024","unstructured":"Fan W, Chen H, Li M, Fan X, Jiang F, Xu C et al (2024) NRF2 activation ameliorates blood\u2013brain barrier injury after cerebral ischemic stroke by regulating ferroptosis and inflammation. Sci Rep 14(1):5300","journal-title":"Sci Rep"},{"issue":"9","key":"9952_CR99","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1248\/bpb.b22-00186","volume":"45","author":"W Liu","year":"2022","unstructured":"Liu W, Wang L, Liu C, Dai Z, Li T, Tang B (2022) Edaravone Ameliorates cerebral ischemia-reperfusion injury by Downregulating Ferroptosis via the Nrf2\/FPN pathway in rats. Biol Pharm Bull 45(9):1269\u20131275","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"9952_CR100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bulcan.2020.11.004","volume":"108","author":"W Cao","year":"2021","unstructured":"Cao W, Li J, Yang K, Cao D (2021) An overview of autophagy: mechanism, regulation and research progress. Bull Cancer 108(3):304\u2013322","journal-title":"Bull Cancer"},{"key":"9952_CR101","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fphar.2019.00551","volume":"10","author":"D Wu","year":"2019","unstructured":"Wu D, Zhang K, Hu P (2019) The role of autophagy in acute myocardial infarction. Front Pharmacol 10:551","journal-title":"Front Pharmacol"},{"issue":"6","key":"9952_CR102","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s12276-020-0455-4","volume":"52","author":"S Jung","year":"2020","unstructured":"Jung S, Jeong H, Yu S-W (2020) Autophagy as a decisive process for cell death. Exp Mol Med 52(6):921\u2013930","journal-title":"Exp Mol Med"},{"issue":"2","key":"9952_CR103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/15548627.2017.1378838","volume":"14","author":"L Yu","year":"2018","unstructured":"Yu L, Chen Y, Tooze SA (2018) Autophagy pathway: cellular and molecular mechanisms. Autophagy 14(2):207\u2013215","journal-title":"Autophagy"},{"issue":"8","key":"9952_CR104","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5483\/BMBRep.2016.49.8.081","volume":"49","author":"Y-K Lee","year":"2016","unstructured":"Lee Y-K, Lee J-A (2016) Role of the mammalian ATG8\/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagy. BMB Rep 49(8):424","journal-title":"BMB Rep"},{"issue":"3","key":"9952_CR105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/cells1030284","volume":"1","author":"J-P Decuypere","year":"2012","unstructured":"Decuypere J-P, Parys JB, Bultynck G (2012) Regulation of the autophagic bcl-2\/beclin 1 interaction. Cells 1(3):284\u2013312","journal-title":"Cells"},{"issue":"2","key":"9952_CR106","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","volume":"13","author":"H P\u00f3pulo","year":"2012","unstructured":"P\u00f3pulo H, Lopes JM, Soares P (2012) The mTOR signalling pathway in human cancer. Int J Mol Sci 13(2):1886\u20131918","journal-title":"Int J Mol Sci"},{"issue":"24","key":"9952_CR107","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1007\/s00018-015-2034-8","volume":"72","author":"S Wesselborg","year":"2015","unstructured":"Wesselborg S, Stork B (2015) Autophagy signal transduction by ATG proteins: from hierarchies to networks. Cell Mol Life Sci 72(24):4721\u20134757","journal-title":"Cell Mol Life Sci"},{"key":"9952_CR108","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fnins.2018.01022","volume":"12","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhu Y, Zhong X, Chen X, Wang J, Ying G (2019) Crosstalk between autophagy and cerebral ischemia. Front Neurosci 12:1022","journal-title":"Front Neurosci"},{"issue":"10","key":"9952_CR109","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1007\/s11064-023-03973-1","volume":"48","author":"J Zhang","year":"2023","unstructured":"Zhang J, Xiao Y, Liu H, Xu L, Guo X, Gao Y et al (2023) Edaravone dexborneol alleviates neuroinflammation by reducing neuroglial cell proliferation and suppresses neuronal apoptosis\/autophagy in vascular dementia rats. Neurochem Res 48(10):3113\u20133128","journal-title":"Neurochem Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09952-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09952-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09952-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:24:26Z","timestamp":1738711466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09952-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9952"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09952-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This is a review study. The TUMS Research Ethics Committee has confirmed that no ethical approval is required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"1007"}}